{"transactions":[{"id":771828,"issuer":{"id":4682,"kind":"organization","name":"TANDEM DIABETES CARE INC"},"owners":[{"id":45971,"kind":"person","name":"Novara Mark David","position":1,"cik":"0002000342","reported_name":"Novara Mark David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CHIEF COMMERCIAL OFFICER"}}],"security":"Restricted Stock Unit","published_at":"2026-05-19T20:02:03.000Z","date":"2026-05-15","kind":"exercise","planned":false,"acquired":false,"shares":10496,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"Awarded on May 30, 2025 pursuant to the 2023 Plan."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2026, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2026, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter."}],"balance_after":20992,"derivative":{"underlying":"Common Stock","underlying_shares":10496},"source":{"system":"sec-edgar","filing":"0001438133-26-000054","document":"wk-form4_1779220921.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1438133/000143813326000054/wk-form4_1779220921.xml","form_type":"4"}},{"id":771827,"issuer":{"id":4682,"kind":"organization","name":"TANDEM DIABETES CARE INC"},"owners":[{"id":45971,"kind":"person","name":"Novara Mark David","position":1,"cik":"0002000342","reported_name":"Novara Mark David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CHIEF COMMERCIAL OFFICER"}}],"security":"Restricted Stock Unit","published_at":"2026-05-19T20:02:03.000Z","date":"2026-05-15","kind":"exercise","planned":false,"acquired":false,"shares":76,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Awarded on May 23, 2024 pursuant to the Tandem Diabetes Care Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan)."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2025, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2025, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter."}],"balance_after":304,"derivative":{"underlying":"Common Stock","underlying_shares":76},"source":{"system":"sec-edgar","filing":"0001438133-26-000054","document":"wk-form4_1779220921.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1438133/000143813326000054/wk-form4_1779220921.xml","form_type":"4"}},{"id":771826,"issuer":{"id":4682,"kind":"organization","name":"TANDEM DIABETES CARE INC"},"owners":[{"id":45971,"kind":"person","name":"Novara Mark David","position":1,"cik":"0002000342","reported_name":"Novara Mark David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-05-19T20:02:03.000Z","date":"2026-05-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":7854,"price":12.82,"value":100688.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld by Tandem Diabetes Care Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold."}],"balance_after":40317,"source":{"system":"sec-edgar","filing":"0001438133-26-000054","document":"wk-form4_1779220921.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1438133/000143813326000054/wk-form4_1779220921.xml","form_type":"4"}},{"id":771825,"issuer":{"id":4682,"kind":"organization","name":"TANDEM DIABETES CARE INC"},"owners":[{"id":45971,"kind":"person","name":"Novara Mark David","position":1,"cik":"0002000342","reported_name":"Novara Mark David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-05-19T20:02:03.000Z","date":"2026-05-15","kind":"exercise","planned":false,"acquired":true,"shares":10496,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":48171,"source":{"system":"sec-edgar","filing":"0001438133-26-000054","document":"wk-form4_1779220921.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1438133/000143813326000054/wk-form4_1779220921.xml","form_type":"4"}},{"id":771824,"issuer":{"id":4682,"kind":"organization","name":"TANDEM DIABETES CARE INC"},"owners":[{"id":45971,"kind":"person","name":"Novara Mark David","position":1,"cik":"0002000342","reported_name":"Novara Mark David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-05-19T20:02:03.000Z","date":"2026-05-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":57,"price":12.82,"value":730.74,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld by Tandem Diabetes Care Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold."}],"balance_after":37675,"source":{"system":"sec-edgar","filing":"0001438133-26-000054","document":"wk-form4_1779220921.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1438133/000143813326000054/wk-form4_1779220921.xml","form_type":"4"}},{"id":771823,"issuer":{"id":4682,"kind":"organization","name":"TANDEM DIABETES CARE INC"},"owners":[{"id":45971,"kind":"person","name":"Novara Mark David","position":1,"cik":"0002000342","reported_name":"Novara Mark David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-05-19T20:02:03.000Z","date":"2026-05-15","kind":"exercise","planned":false,"acquired":true,"shares":76,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":37732,"source":{"system":"sec-edgar","filing":"0001438133-26-000054","document":"wk-form4_1779220921.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1438133/000143813326000054/wk-form4_1779220921.xml","form_type":"4"}},{"id":834829,"issuer":{"id":4682,"kind":"organization","name":"TANDEM DIABETES CARE INC"},"owners":[{"id":45971,"kind":"person","name":"Novara Mark David","position":1,"cik":"0002000342","reported_name":"Novara Mark David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CHIEF COMMERCIAL OFFICER"}}],"security":"Restricted Stock Unit","published_at":"2026-03-18T20:06:02.000Z","date":"2026-03-16","kind":"exercise","planned":false,"acquired":false,"shares":7414,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Awarded on December 15, 2023 pursuant to the Tandem Diabetes Care Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan)."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 12/15/2024, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 12/15/2024, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter."}],"balance_after":22244,"derivative":{"underlying":"Common Stock","underlying_shares":7414},"source":{"system":"sec-edgar","filing":"0001438133-26-000023","document":"wk-form4_1773864360.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1438133/000143813326000023/wk-form4_1773864360.xml","form_type":"4"}},{"id":834828,"issuer":{"id":4682,"kind":"organization","name":"TANDEM DIABETES CARE INC"},"owners":[{"id":45971,"kind":"person","name":"Novara Mark David","position":1,"cik":"0002000342","reported_name":"Novara Mark David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-03-18T20:06:02.000Z","date":"2026-03-17","kind":"sale","planned":false,"acquired":false,"shares":187,"price":23.05,"value":4310.35,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 4, 2025."}],"balance_after":37656,"source":{"system":"sec-edgar","filing":"0001438133-26-000023","document":"wk-form4_1773864360.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1438133/000143813326000023/wk-form4_1773864360.xml","form_type":"4"}},{"id":834827,"issuer":{"id":4682,"kind":"organization","name":"TANDEM DIABETES CARE INC"},"owners":[{"id":45971,"kind":"person","name":"Novara Mark David","position":1,"cik":"0002000342","reported_name":"Novara Mark David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-03-18T20:06:02.000Z","date":"2026-03-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":5540,"price":21.59,"value":119608.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld by Tandem Diabetes Care Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold."}],"balance_after":37843,"source":{"system":"sec-edgar","filing":"0001438133-26-000023","document":"wk-form4_1773864360.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1438133/000143813326000023/wk-form4_1773864360.xml","form_type":"4"}},{"id":834826,"issuer":{"id":4682,"kind":"organization","name":"TANDEM DIABETES CARE INC"},"owners":[{"id":45971,"kind":"person","name":"Novara Mark David","position":1,"cik":"0002000342","reported_name":"Novara Mark David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-03-18T20:06:02.000Z","date":"2026-03-16","kind":"exercise","planned":false,"acquired":true,"shares":7414,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":43383,"source":{"system":"sec-edgar","filing":"0001438133-26-000023","document":"wk-form4_1773864360.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1438133/000143813326000023/wk-form4_1773864360.xml","form_type":"4"}},{"id":853404,"issuer":{"id":4682,"kind":"organization","name":"TANDEM DIABETES CARE INC"},"owners":[{"id":45971,"kind":"person","name":"Novara Mark David","position":1,"cik":"0002000342","reported_name":"Novara Mark David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-03-09T20:27:14.000Z","date":"2026-03-05","kind":"sale","planned":true,"acquired":false,"shares":2,"price":22.81,"value":45.62,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 4, 2025."}],"balance_after":35969,"source":{"system":"sec-edgar","filing":"0001438133-26-000022","document":"wk-form4_1773088030.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1438133/000143813326000022/wk-form4_1773088030.xml","form_type":"4"}},{"id":893207,"issuer":{"id":4682,"kind":"organization","name":"TANDEM DIABETES CARE INC"},"owners":[{"id":45971,"kind":"person","name":"Novara Mark David","position":1,"cik":"0002000342","reported_name":"Novara Mark David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CHIEF COMMERCIAL OFFICER"}}],"security":"Restricted Stock Unit","published_at":"2026-02-19T21:36:33.000Z","date":"2026-02-17","kind":"exercise","planned":false,"acquired":false,"shares":77,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Awarded on May 23, 2024 pursuant to the Tandem Diabetes Care Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan)."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2025, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2025, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter."}],"balance_after":380,"derivative":{"underlying":"Common Stock","underlying_shares":77},"source":{"system":"sec-edgar","filing":"0001438133-26-000016","document":"wk-form4_1771536990.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1438133/000143813326000016/wk-form4_1771536990.xml","form_type":"4"}},{"id":893206,"issuer":{"id":4682,"kind":"organization","name":"TANDEM DIABETES CARE INC"},"owners":[{"id":45971,"kind":"person","name":"Novara Mark David","position":1,"cik":"0002000342","reported_name":"Novara Mark David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-02-19T21:36:33.000Z","date":"2026-02-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":62,"price":18.95,"value":1174.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld by Tandem Diabetes Care Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold."}],"balance_after":35971,"source":{"system":"sec-edgar","filing":"0001438133-26-000016","document":"wk-form4_1771536990.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1438133/000143813326000016/wk-form4_1771536990.xml","form_type":"4"}},{"id":893205,"issuer":{"id":4682,"kind":"organization","name":"TANDEM DIABETES CARE INC"},"owners":[{"id":45971,"kind":"person","name":"Novara Mark David","position":1,"cik":"0002000342","reported_name":"Novara Mark David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-02-19T21:36:33.000Z","date":"2026-02-17","kind":"exercise","planned":false,"acquired":true,"shares":77,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":36033,"source":{"system":"sec-edgar","filing":"0001438133-26-000016","document":"wk-form4_1771536990.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1438133/000143813326000016/wk-form4_1771536990.xml","form_type":"4"}},{"id":964847,"issuer":{"id":4682,"kind":"organization","name":"TANDEM DIABETES CARE INC"},"owners":[{"id":45971,"kind":"person","name":"Novara Mark David","position":1,"cik":"0002000342","reported_name":"Novara Mark David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CHIEF COMMERCIAL OFFICER"}}],"security":"Restricted Stock Unit","published_at":"2025-12-17T21:02:14.000Z","date":"2025-12-15","kind":"exercise","planned":false,"acquired":false,"shares":7415,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Awarded on December 15, 2023 pursuant to the Tandem Diabetes Care Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan)."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 12/15/2024, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 12/15/2024, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter."}],"balance_after":29658,"derivative":{"underlying":"Common Stock","underlying_shares":7415},"source":{"system":"sec-edgar","filing":"0001438133-25-000229","document":"wk-form4_1766005331.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1438133/000143813325000229/wk-form4_1766005331.xml","form_type":"4"}},{"id":964846,"issuer":{"id":4682,"kind":"organization","name":"TANDEM DIABETES CARE INC"},"owners":[{"id":45971,"kind":"person","name":"Novara Mark David","position":1,"cik":"0002000342","reported_name":"Novara Mark David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-12-17T21:02:14.000Z","date":"2025-12-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":3843,"price":22.11,"value":84968.73,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld by Tandem Diabetes Care Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold."}],"balance_after":35956,"source":{"system":"sec-edgar","filing":"0001438133-25-000229","document":"wk-form4_1766005331.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1438133/000143813325000229/wk-form4_1766005331.xml","form_type":"4"}},{"id":964845,"issuer":{"id":4682,"kind":"organization","name":"TANDEM DIABETES CARE INC"},"owners":[{"id":45971,"kind":"person","name":"Novara Mark David","position":1,"cik":"0002000342","reported_name":"Novara Mark David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-12-17T21:02:14.000Z","date":"2025-12-15","kind":"exercise","planned":false,"acquired":true,"shares":7415,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":39799,"source":{"system":"sec-edgar","filing":"0001438133-25-000229","document":"wk-form4_1766005331.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1438133/000143813325000229/wk-form4_1766005331.xml","form_type":"4"}},{"id":993702,"issuer":{"id":4682,"kind":"organization","name":"TANDEM DIABETES CARE INC"},"owners":[{"id":45971,"kind":"person","name":"Novara Mark David","position":1,"cik":"0002000342","reported_name":"Novara Mark David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CHIEF COMMERCIAL OFFICER"}}],"security":"Restricted Stock Unit","published_at":"2025-11-19T21:06:41.000Z","date":"2025-11-17","kind":"exercise","planned":false,"acquired":false,"shares":76,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Awarded on May 23, 2024 pursuant to the Tandem Diabetes Care Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan)."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2025, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2025, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter."}],"balance_after":457,"derivative":{"underlying":"Common Stock","underlying_shares":76},"source":{"system":"sec-edgar","filing":"0001438133-25-000210","document":"wk-form4_1763586398.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1438133/000143813325000210/wk-form4_1763586398.xml","form_type":"4"}},{"id":993701,"issuer":{"id":4682,"kind":"organization","name":"TANDEM DIABETES CARE INC"},"owners":[{"id":45971,"kind":"person","name":"Novara Mark David","position":1,"cik":"0002000342","reported_name":"Novara Mark David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-11-19T21:06:41.000Z","date":"2025-11-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":40,"price":18.61,"value":744.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld by Tandem Diabetes Care Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold."}],"balance_after":32384,"source":{"system":"sec-edgar","filing":"0001438133-25-000210","document":"wk-form4_1763586398.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1438133/000143813325000210/wk-form4_1763586398.xml","form_type":"4"}},{"id":993700,"issuer":{"id":4682,"kind":"organization","name":"TANDEM DIABETES CARE INC"},"owners":[{"id":45971,"kind":"person","name":"Novara Mark David","position":1,"cik":"0002000342","reported_name":"Novara Mark David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-11-19T21:06:41.000Z","date":"2025-11-17","kind":"exercise","planned":false,"acquired":true,"shares":76,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":32424,"source":{"system":"sec-edgar","filing":"0001438133-25-000210","document":"wk-form4_1763586398.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1438133/000143813325000210/wk-form4_1763586398.xml","form_type":"4"}},{"id":1039273,"issuer":{"id":4682,"kind":"organization","name":"TANDEM DIABETES CARE INC"},"owners":[{"id":45971,"kind":"person","name":"Novara Mark David","position":1,"cik":"0002000342","reported_name":"Novara Mark David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CHIEF COMMERCIAL OFFICER"}}],"security":"Restricted Stock Unit","published_at":"2025-09-16T20:47:08.000Z","date":"2025-09-15","kind":"exercise","planned":false,"acquired":false,"shares":7415,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Awarded on December 15, 2023 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan)."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 12/15/2024, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 12/15/2024, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter."}],"balance_after":37073,"derivative":{"underlying":"Common Stock","underlying_shares":7415},"source":{"system":"sec-edgar","filing":"0001438133-25-000173","document":"wk-form4_1758055625.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1438133/000143813325000173/wk-form4_1758055625.xml","form_type":"4"}},{"id":1039272,"issuer":{"id":4682,"kind":"organization","name":"TANDEM DIABETES CARE INC"},"owners":[{"id":45971,"kind":"person","name":"Novara Mark David","position":1,"cik":"0002000342","reported_name":"Novara Mark David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-09-16T20:47:08.000Z","date":"2025-09-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":3866,"price":12.09,"value":46739.94,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold."}],"balance_after":32348,"source":{"system":"sec-edgar","filing":"0001438133-25-000173","document":"wk-form4_1758055625.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1438133/000143813325000173/wk-form4_1758055625.xml","form_type":"4"}},{"id":1039271,"issuer":{"id":4682,"kind":"organization","name":"TANDEM DIABETES CARE INC"},"owners":[{"id":45971,"kind":"person","name":"Novara Mark David","position":1,"cik":"0002000342","reported_name":"Novara Mark David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-09-16T20:47:08.000Z","date":"2025-09-15","kind":"exercise","planned":false,"acquired":true,"shares":7415,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":36214,"source":{"system":"sec-edgar","filing":"0001438133-25-000173","document":"wk-form4_1758055625.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1438133/000143813325000173/wk-form4_1758055625.xml","form_type":"4"}},{"id":1061757,"issuer":{"id":4682,"kind":"organization","name":"TANDEM DIABETES CARE INC"},"owners":[{"id":45971,"kind":"person","name":"Novara Mark David","position":1,"cik":"0002000342","reported_name":"Novara Mark David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CHIEF COMMERCIAL OFFICER"}}],"security":"Restricted Stock Unit","published_at":"2025-08-19T22:14:50.000Z","date":"2025-08-15","kind":"exercise","planned":false,"acquired":false,"shares":76,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Awarded on May 23, 2024 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan)."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2025, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2025, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter."}],"balance_after":533,"derivative":{"underlying":"Common Stock","underlying_shares":40},"source":{"system":"sec-edgar","filing":"0001628280-25-040846","document":"wk-form4_1755641686.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1438133/000162828025040846/wk-form4_1755641686.xml","form_type":"4"}},{"id":1061756,"issuer":{"id":4682,"kind":"organization","name":"TANDEM DIABETES CARE INC"},"owners":[{"id":45971,"kind":"person","name":"Novara Mark David","position":1,"cik":"0002000342","reported_name":"Novara Mark David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-08-19T22:14:50.000Z","date":"2025-08-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":40,"price":10.82,"value":432.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold."}],"balance_after":28799,"source":{"system":"sec-edgar","filing":"0001628280-25-040846","document":"wk-form4_1755641686.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1438133/000162828025040846/wk-form4_1755641686.xml","form_type":"4"}},{"id":1061755,"issuer":{"id":4682,"kind":"organization","name":"TANDEM DIABETES CARE INC"},"owners":[{"id":45971,"kind":"person","name":"Novara Mark David","position":1,"cik":"0002000342","reported_name":"Novara Mark David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-08-19T22:14:50.000Z","date":"2025-08-15","kind":"exercise","planned":false,"acquired":true,"shares":76,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":28839,"source":{"system":"sec-edgar","filing":"0001628280-25-040846","document":"wk-form4_1755641686.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1438133/000162828025040846/wk-form4_1755641686.xml","form_type":"4"}},{"id":1106169,"issuer":{"id":4682,"kind":"organization","name":"TANDEM DIABETES CARE INC"},"owners":[{"id":45971,"kind":"person","name":"Novara Mark David","position":1,"cik":"0002000342","reported_name":"Novara Mark David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CHIEF COMMERCIAL OFFICER"}}],"security":"Restricted Stock Unit","published_at":"2025-06-18T20:08:21.000Z","date":"2025-06-16","kind":"exercise","planned":false,"acquired":false,"shares":7414,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Awarded on December 15, 2023 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan)."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"RSU vest as to thiry-three percent (33%) of the total number of shares subject to the RSU on 12/15/2024, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"RSU vest as to thiry-three percent (33%) of the total number of shares subject to the RSU on 12/15/2024, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter."}],"balance_after":44488,"derivative":{"underlying":"Common Stock","underlying_shares":7414},"source":{"system":"sec-edgar","filing":"0001438133-25-000142","document":"wk-form4_1750277294.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1438133/000143813325000142/wk-form4_1750277294.xml","form_type":"4"}},{"id":1106168,"issuer":{"id":4682,"kind":"organization","name":"TANDEM DIABETES CARE INC"},"owners":[{"id":45971,"kind":"person","name":"Novara Mark David","position":1,"cik":"0002000342","reported_name":"Novara Mark David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-06-18T20:08:21.000Z","date":"2025-06-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":3846,"price":20.76,"value":79842.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold."}],"balance_after":28763,"source":{"system":"sec-edgar","filing":"0001438133-25-000142","document":"wk-form4_1750277294.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1438133/000143813325000142/wk-form4_1750277294.xml","form_type":"4"}},{"id":1106167,"issuer":{"id":4682,"kind":"organization","name":"TANDEM DIABETES CARE INC"},"owners":[{"id":45971,"kind":"person","name":"Novara Mark David","position":1,"cik":"0002000342","reported_name":"Novara Mark David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-06-18T20:08:21.000Z","date":"2025-06-16","kind":"exercise","planned":false,"acquired":true,"shares":7414,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":32609,"source":{"system":"sec-edgar","filing":"0001438133-25-000142","document":"wk-form4_1750277294.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1438133/000143813325000142/wk-form4_1750277294.xml","form_type":"4"}},{"id":1121199,"issuer":{"id":4682,"kind":"organization","name":"TANDEM DIABETES CARE INC"},"owners":[{"id":45971,"kind":"person","name":"Novara Mark David","position":1,"cik":"0002000342","reported_name":"Novara Mark David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CHIEF COMMERCIAL OFFICER"}}],"security":"Restricted Stock Unit","published_at":"2025-06-05T21:26:57.000Z","date":"2025-05-30","kind":"grant","planned":false,"acquired":true,"shares":31488,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Awarded on May 30, 2025 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan)."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2026, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2026, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter."}],"balance_after":31488,"derivative":{"underlying":"Common Stock","underlying_shares":31488},"source":{"system":"sec-edgar","filing":"0001438133-25-000134","document":"wk-form4_1749158611.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1438133/000143813325000134/wk-form4_1749158611.xml","form_type":"4"}},{"id":1121198,"issuer":{"id":4682,"kind":"organization","name":"TANDEM DIABETES CARE INC"},"owners":[{"id":45971,"kind":"person","name":"Novara Mark David","position":1,"cik":"0002000342","reported_name":"Novara Mark David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CHIEF COMMERCIAL OFFICER"}}],"security":"Performance Stock Unit","published_at":"2025-06-05T21:26:57.000Z","date":"2025-05-30","kind":"grant","planned":false,"acquired":true,"shares":31486,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Awarded on May 30, 2025 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan)."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each performance stock unit (PSU) represents a contingent right to receive one share of Tandem Diabetes Care, Inc. (the Company) common stock based upon the achievement of certain pre-defined performance metrics\nas of December 31, 2027 (the Measurement Date). The number of shares issued may range from 0% to 200% of the amount specified above, based upon (i) Company's actual performance relative to the pre-defined\nperformance metrics, and (ii) subject to the awardee's continuing service through the Measurement Date. If minimum performance metrics are not met, no PSUs will vest."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each performance stock unit (PSU) represents a contingent right to receive one share of Tandem Diabetes Care, Inc. (the Company) common stock based upon the achievement of certain pre-defined performance metrics\nas of December 31, 2027 (the Measurement Date). The number of shares issued may range from 0% to 200% of the amount specified above, based upon (i) Company's actual performance relative to the pre-defined\nperformance metrics, and (ii) subject to the awardee's continuing service through the Measurement Date. If minimum performance metrics are not met, no PSUs will vest."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each performance stock unit (PSU) represents a contingent right to receive one share of Tandem Diabetes Care, Inc. (the Company) common stock based upon the achievement of certain pre-defined performance metrics\nas of December 31, 2027 (the Measurement Date). The number of shares issued may range from 0% to 200% of the amount specified above, based upon (i) Company's actual performance relative to the pre-defined\nperformance metrics, and (ii) subject to the awardee's continuing service through the Measurement Date. If minimum performance metrics are not met, no PSUs will vest."}],"balance_after":31486,"derivative":{"underlying":"Common Stock","underlying_shares":31486},"source":{"system":"sec-edgar","filing":"0001438133-25-000134","document":"wk-form4_1749158611.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1438133/000143813325000134/wk-form4_1749158611.xml","form_type":"4"}},{"id":1142498,"issuer":{"id":4682,"kind":"organization","name":"TANDEM DIABETES CARE INC"},"owners":[{"id":45971,"kind":"person","name":"Novara Mark David","position":1,"cik":"0002000342","reported_name":"Novara Mark David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CHIEF COMMERCIAL OFFICER"}}],"security":"Restricted Stock Unit","published_at":"2025-05-19T22:06:58.000Z","date":"2025-05-15","kind":"exercise","planned":false,"acquired":false,"shares":304,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Awarded on May 23, 2024 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan)."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2025, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2025, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter."}],"balance_after":609,"derivative":{"underlying":"Common Stock","underlying_shares":304},"source":{"system":"sec-edgar","filing":"0001438133-25-000089","document":"wk-form4_1747692404.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1438133/000143813325000089/wk-form4_1747692404.xml","form_type":"4"}},{"id":1142497,"issuer":{"id":4682,"kind":"organization","name":"TANDEM DIABETES CARE INC"},"owners":[{"id":45971,"kind":"person","name":"Novara Mark David","position":1,"cik":"0002000342","reported_name":"Novara Mark David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-05-19T22:06:58.000Z","date":"2025-05-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":113,"price":22.7,"value":2565.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold."}],"balance_after":25195,"source":{"system":"sec-edgar","filing":"0001438133-25-000089","document":"wk-form4_1747692404.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1438133/000143813325000089/wk-form4_1747692404.xml","form_type":"4"}},{"id":1142496,"issuer":{"id":4682,"kind":"organization","name":"TANDEM DIABETES CARE INC"},"owners":[{"id":45971,"kind":"person","name":"Novara Mark David","position":1,"cik":"0002000342","reported_name":"Novara Mark David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-05-19T22:06:58.000Z","date":"2025-05-15","kind":"exercise","planned":false,"acquired":true,"shares":304,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":25308,"source":{"system":"sec-edgar","filing":"0001438133-25-000089","document":"wk-form4_1747692404.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1438133/000143813325000089/wk-form4_1747692404.xml","form_type":"4"}},{"id":1142495,"issuer":{"id":4682,"kind":"organization","name":"TANDEM DIABETES CARE INC"},"owners":[{"id":45971,"kind":"person","name":"Novara Mark David","position":1,"cik":"0002000342","reported_name":"Novara Mark David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-05-19T22:06:58.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":870,"price":19.3,"value":16791.0,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of shares of common stock pursuant to the Tandem Diabetes Care, Inc. Amended and Restated 2013 Employee Stock Purchase Plan (ESPP), for the ESPP purchase period of November 18, 2024, through May 15, 2025. This transaction is also exempt under Rule 16b-3(c)."}],"balance_after":25004,"source":{"system":"sec-edgar","filing":"0001438133-25-000089","document":"wk-form4_1747692404.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1438133/000143813325000089/wk-form4_1747692404.xml","form_type":"4"}},{"id":1196981,"issuer":{"id":4682,"kind":"organization","name":"TANDEM DIABETES CARE INC"},"owners":[{"id":45971,"kind":"person","name":"Novara Mark David","position":1,"cik":"0002000342","reported_name":"Novara Mark David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CHIEF COMMERCIAL OFFICER"}}],"security":"Restricted Stock Unit","published_at":"2025-03-19T20:12:32.000Z","date":"2025-03-17","kind":"exercise","planned":false,"acquired":false,"shares":7415,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Awarded on December 15, 2023 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan)."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 12/15/2024, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 12/15/2024, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter."}],"balance_after":51902,"derivative":{"underlying":"Common Stock","underlying_shares":7415},"source":{"system":"sec-edgar","filing":"0001438133-25-000046","document":"wk-form4_1742415145.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1438133/000143813325000046/wk-form4_1742415145.xml","form_type":"4"}},{"id":1196980,"issuer":{"id":4682,"kind":"organization","name":"TANDEM DIABETES CARE INC"},"owners":[{"id":45971,"kind":"person","name":"Novara Mark David","position":1,"cik":"0002000342","reported_name":"Novara Mark David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-03-19T20:12:32.000Z","date":"2025-03-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":2739,"price":19.17,"value":52506.63,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold."}],"balance_after":24134,"source":{"system":"sec-edgar","filing":"0001438133-25-000046","document":"wk-form4_1742415145.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1438133/000143813325000046/wk-form4_1742415145.xml","form_type":"4"}},{"id":1196979,"issuer":{"id":4682,"kind":"organization","name":"TANDEM DIABETES CARE INC"},"owners":[{"id":45971,"kind":"person","name":"Novara Mark David","position":1,"cik":"0002000342","reported_name":"Novara Mark David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-03-19T20:12:32.000Z","date":"2025-03-17","kind":"exercise","planned":false,"acquired":true,"shares":7415,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":26873,"source":{"system":"sec-edgar","filing":"0001438133-25-000046","document":"wk-form4_1742415145.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1438133/000143813325000046/wk-form4_1742415145.xml","form_type":"4"}},{"id":1326535,"issuer":{"id":4682,"kind":"organization","name":"TANDEM DIABETES CARE INC"},"owners":[{"id":45971,"kind":"person","name":"Novara Mark David","position":1,"cik":"0002000342","reported_name":"Novara Mark David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CHIEF COMMERCIAL OFFICER"}}],"security":"Restricted Stock Unit","published_at":"2024-12-18T21:57:12.000Z","date":"2024-12-16","kind":"exercise","planned":false,"acquired":false,"shares":29658,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Awarded on December 15, 2023 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan)."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"RSU vest as to thiry-three percent (33%) of the total number of shares subject to the RSU on 12/15/2024, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"RSU vest as to thiry-three percent (33%) of the total number of shares subject to the RSU on 12/15/2024, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter."}],"balance_after":59317,"derivative":{"underlying":"Common Stock","underlying_shares":29658},"source":{"system":"sec-edgar","filing":"0001438133-24-000221","document":"wk-form4_1734559026.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1438133/000143813324000221/wk-form4_1734559026.xml","form_type":"4"}},{"id":1326534,"issuer":{"id":4682,"kind":"organization","name":"TANDEM DIABETES CARE INC"},"owners":[{"id":45971,"kind":"person","name":"Novara Mark David","position":1,"cik":"0002000342","reported_name":"Novara Mark David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-12-18T21:57:12.000Z","date":"2024-12-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":10732,"price":32.66,"value":350507.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold."}],"balance_after":19458,"source":{"system":"sec-edgar","filing":"0001438133-24-000221","document":"wk-form4_1734559026.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1438133/000143813324000221/wk-form4_1734559026.xml","form_type":"4"}},{"id":1326533,"issuer":{"id":4682,"kind":"organization","name":"TANDEM DIABETES CARE INC"},"owners":[{"id":45971,"kind":"person","name":"Novara Mark David","position":1,"cik":"0002000342","reported_name":"Novara Mark David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-12-18T21:57:12.000Z","date":"2024-12-16","kind":"exercise","planned":false,"acquired":true,"shares":29658,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":30190,"source":{"system":"sec-edgar","filing":"0001438133-24-000221","document":"wk-form4_1734559026.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1438133/000143813324000221/wk-form4_1734559026.xml","form_type":"4"}},{"id":1358925,"issuer":{"id":4682,"kind":"organization","name":"TANDEM DIABETES CARE INC"},"owners":[{"id":45971,"kind":"person","name":"Novara Mark David","position":1,"cik":"0002000342","reported_name":"Novara Mark David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-11-19T22:23:14.000Z","date":"2024-11-15","kind":"purchase","planned":false,"acquired":true,"shares":532,"price":23.24,"value":12363.68,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of shares of common stock pursuant to the Tandem Diabetes Care, Inc. Amended and Restated 2013 Employee Stock Purchase Plan (ESPP), for the ESPP purchase period of May 16, 2024 through November 15, 2024. This transaction is also exempt under Rule 16b-3(c)."}],"balance_after":532,"source":{"system":"sec-edgar","filing":"0001438133-24-000215","document":"wk-form4_1732054988.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1438133/000143813324000215/wk-form4_1732054988.xml","form_type":"4"}},{"id":1500269,"issuer":{"id":4682,"kind":"organization","name":"TANDEM DIABETES CARE INC"},"owners":[{"id":45971,"kind":"person","name":"Novara Mark David","position":1,"cik":"0002000342","reported_name":"Novara Mark David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CHIEF COMMERCIAL OFFICER"}}],"security":"Performance Stock Unit","published_at":"2024-05-28T22:44:26.000Z","date":"2024-05-23","kind":"grant","planned":false,"acquired":true,"shares":913,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Awarded on May 23, 2024 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan (the 2023 Plan)."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each performance stock unit (PSU) represents a contingent right to receive one share of Tandem Diabetes Care, Inc. (the Company) common stock based upon the achievement of certain pre-defined performance metrics as of December 31, 2026 (the Measurement Date). The number of shares issued may range from 0% to 200% of the amount specified above, based upon (i) Company's actual performance relative to the pre-defined performance metrics, and (ii) subject to the awardee's continuing service through the Measurement Date. If minimum performance metrics are not met, no PSUs will vest."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each performance stock unit (PSU) represents a contingent right to receive one share of Tandem Diabetes Care, Inc. (the Company) common stock based upon the achievement of certain pre-defined performance metrics as of December 31, 2026 (the Measurement Date). The number of shares issued may range from 0% to 200% of the amount specified above, based upon (i) Company's actual performance relative to the pre-defined performance metrics, and (ii) subject to the awardee's continuing service through the Measurement Date. If minimum performance metrics are not met, no PSUs will vest."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each performance stock unit (PSU) represents a contingent right to receive one share of Tandem Diabetes Care, Inc. (the Company) common stock based upon the achievement of certain pre-defined performance metrics as of December 31, 2026 (the Measurement Date). The number of shares issued may range from 0% to 200% of the amount specified above, based upon (i) Company's actual performance relative to the pre-defined performance metrics, and (ii) subject to the awardee's continuing service through the Measurement Date. If minimum performance metrics are not met, no PSUs will vest."}],"balance_after":913,"derivative":{"underlying":"Common Stock","underlying_shares":913},"source":{"system":"sec-edgar","filing":"0001438133-24-000140","document":"wk-form4_1716936259.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1438133/000143813324000140/wk-form4_1716936259.xml","form_type":"4"}},{"id":1500268,"issuer":{"id":4682,"kind":"organization","name":"TANDEM DIABETES CARE INC"},"owners":[{"id":45971,"kind":"person","name":"Novara Mark David","position":1,"cik":"0002000342","reported_name":"Novara Mark David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CHIEF COMMERCIAL OFFICER"}}],"security":"Restricted Stock Unit","published_at":"2024-05-28T22:44:26.000Z","date":"2024-05-23","kind":"grant","planned":false,"acquired":true,"shares":913,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Awarded on May 23, 2024 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan (the 2023 Plan)."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2025, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2025, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter."}],"balance_after":913,"derivative":{"underlying":"Common Stock","underlying_shares":913},"source":{"system":"sec-edgar","filing":"0001438133-24-000140","document":"wk-form4_1716936259.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1438133/000143813324000140/wk-form4_1716936259.xml","form_type":"4"}},{"id":1704724,"issuer":{"id":4682,"kind":"organization","name":"TANDEM DIABETES CARE INC"},"owners":[{"id":45971,"kind":"person","name":"Novara Mark David","position":1,"cik":"0002000342","reported_name":"Novara Mark David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CHIEF COMMERCIAL OFFICER"}}],"security":"Restricted Stock Unit","published_at":"2023-12-19T21:18:02.000Z","date":"2023-12-15","kind":"grant","planned":false,"acquired":true,"shares":88975,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Awarded on December 15, 2023 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan (the 2023 Plan)."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Awarded on December 15, 2023 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan (the 2023 Plan)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted stock units (RSU) vest as to thiry-three percent (33%) of the total number of shares subject to the RSU on 12/15/2024, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted stock units (RSU) vest as to thiry-three percent (33%) of the total number of shares subject to the RSU on 12/15/2024, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter."}],"balance_after":88975,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":88975},"source":{"system":"sec-edgar","filing":"0001438133-23-000258","document":"wk-form4_1703020671.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1438133/000143813323000258/wk-form4_1703020671.xml","form_type":"4"}}]}